Ian Hardy
Chief Executive Officer at Adaptive Phage Therapeutics, Inc.
Profile
Ian Hardy has held the following positions in his career: Chairman & Chief Executive Officer at Adaptive Phage Therapeutics, Inc. and Vice President at Deerfield Management Co. LP (Private Equity).
He is currently working in these roles.
Ian Hardy active positions
| Companies | Position | Start |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 2019-03-31 |
Adaptive Phage Therapeutics, Inc.
 Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | Commercial Services |
- Stock Market
- Insiders
- Ian Hardy
